Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20
- The American Society of Clinical Oncology (ASCO) is a platform for cancer experts to share views on the latest advancements and new approaches in cancer research and was held virtually this year due to the COVID-19 pandemic
- Janssen highlights its oncology portfolio, Merck & Pfizer demonstrated the potential of Bavencio in GTT while AstraZeneca showcased its leadership in lung cancer across early- and late-stage disease and reinforce its biomarker-driven approach
- Our team at PharmaShots has summarized and complied the key events of ASCO 2020
Date- May 14, 2020
Products- Tiragolumab
02. AstraZeneca Reports Results of Tagrisso (osimertinib) in P-III ADAURA Study for EGFR-Mutated Lung Cancer #ASCO20
Date- May 28, 2019
Products- Tagrisso
Date- May 28, 2019
Products- Enhertu
Date- May 28, 2019
Products- Pralsetinib
Date- May 28, 2020
Products- Keytruda
06. Forma Therapeutics Highlights Clinical Data of Olutasidenib At ASCO20 Virtual Scientific Program
Date- May 28, 2020
Product- Olutasidenib
07. Ziopharm Reports Updated Results of Ad-RTS-hIL-12 + Veledimex for Recurrent Glioblastoma #ASCO20
Date- May 28, 2020
Products- Ad-RTS-hIL-12, Veledimex
Date- May 28, 2020
Products- Bavencio
09. Adaptimmune Reports Clinical Update of ADP-A2M4 for Multiple Cancer Indication ASCO20 #ASCO20
Date- May 29, 2020
Products- ADP-A2M4
Date- May 29, 2020
Products- NBTXR3
Date- May 29, 2020
Products- N/A
12. Iovance Reports Updated Clinical Data of Lifileucel in C-144-01 Study for Advanced Melanoma #ASCO20
Date- May 29, 2020
Products- Lifileucel
Date- May 29, 2020
Products- Tivozanib
Date- May 29, 2020
Products- AUTO3
Date- May 29, 2020
Products- Onvansertib
16. Trillium Therapeutics Provides Update on the P-I Dose Escalation Study of TTI-622 #ASCO20
Date- May 29, 2020
Products- TTI-622
Date- May 29, 2020
Products- Mirvetuximab Soravtansine, Avastin
Date- May 29, 2020
Products- HS-110, Nivolumab
Date- May 29, 2020
Products- Qinlock
Date- May 29, 2020
Products- Rebastinib
Date- May 29, 2020
Products- Tipifarnib
Date- May 29, 2020
Products- SBT6050, Trastuzumab
Date- May 29, 2020
Products- Tukysa
Date- May 29, 2020
Products- GB1275
Date- May 29, 2020
Products- Enhertu
26. Athenex Reports Interim Data of Oral Paclitaxel P-II Study for Cutaneous Angiosarcoma #ASCO20
Date- May 29, 2020
Products- Paclitaxel
27. Alligator Bioscience Reports Results of ATOR-1015 in P-I Study for Metastatic Cancer #ASCO20
Date- May 29, 2020
Products- ATOR-1015
Date- May 29, 2020
Products- PolyPEPI1018
29. Myovant Sciences Reports Positive Efficacy and CV Safety Data of Relugolix in P-III HERO Study for Advanced Prostate Cancer #ASCO20
Date- May 29, 2020
Products- Relugolix
Date- May 29, 2020
Products- JNJ-4528, Erleada, Amivantamab, Teclistamab
31. Roche Reports Results of Alecensa in P-III ALEX Study for ALK-Positive Non-Small Cell Lung Cancer #ASCO20
Date- May 29, 2020
Product- Alecensa
Date- May 29, 2020
Product- Imfinzi
Date- May 29, 2020
Products- Imfinzi, Tremelimumab
Date- May 29, 2020
Product- Tislelizumab
35. Amgen Reports Clinical Data of AMG 510 in CodeBreaK 100 Study for Multiple Solid Tumors #ASCO20
Date- May 29, 2020
Product- AMG 510
36. Amphivena Reports Data from First-in-Human Study of AMV564 for Patients with Solid Tumor #ASCO 2020
Date- May 30, 2020
Products- AMV564
Date- May 30, 2019
Products- Iclusig
38. Taiho Oncology Presents Data of Futibatinib in Advanced Intrahepatic Cholangiocarcinoma at #ASCO20
Date- May 31, 2020
Product- Futibatinib
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com